Literature DB >> 34135438

Nanoscale spatial dependence of avidity in an IgG1 antibody.

Agnieszka Jendroszek1,2, Magnus Kjaergaard3,4,5,6.   

Abstract

Antibodies are secreted proteins that are crucial to recognition of pathogens by the immune system and are also efficient pharmaceuticals. The affinity and specificity of target recognition can increase remarkably through avidity effects, when the antibody can bind a multivalent antigen through more than one epitope simultaneously. A key goal of antibody engineering is thus to optimize avidity, but little is known about the nanoscale spatial dependence of avidity in antibodies. Here, we develop a set of anti-parallel coiled-coils spanning from 7 to 20 nm and validate their structure using biophysical techniques. We use the coiled-coils to control the spacing between two epitopes, and measure how antigen spacing affects the stability of the bivalent antibody:antigen complex. We find a maximal avidity enhancement at a spacing of 13 nm. In contrast to recent studies, we find the avidity to be relatively insensitive to epitope spacing near the avidity maximum as long as it is within the spatial tolerance of the antibody. We thus only see a ~ twofold variation of avidity in the range from 7 to 20 nm. The coiled-coil systems developed here may prove a useful protein nanocaliper for profiling the spatial tolerance and avidity profile of bispecific antibodies.

Entities:  

Year:  2021        PMID: 34135438     DOI: 10.1038/s41598-021-92280-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  29 in total

1.  Contrasting IgG structures reveal extreme asymmetry and flexibility.

Authors:  Erica Ollmann Saphire; Robyn L Stanfield; M D Max Crispin; Paul W H I Parren; Pauline M Rudd; Raymond A Dwek; Dennis R Burton; Ian A Wilson
Journal:  J Mol Biol       Date:  2002-05-24       Impact factor: 5.469

Review 2.  On the roles of polyvalent binding in immune recognition: perspectives in the nanoscience of immunology and the immune response to nanomedicines.

Authors:  Thomas Vorup-Jensen
Journal:  Adv Drug Deliv Rev       Date:  2012-06-15       Impact factor: 15.470

3.  Influence of spacer-receptor interactions on the stability of bivalent ligand-receptor complexes.

Authors:  Jorge Numata; Alok Juneja; Dennis J Diestler; Ernst-Walter Knapp
Journal:  J Phys Chem B       Date:  2012-02-15       Impact factor: 2.991

4.  Statistical thermodynamics of the stability of multivalent ligand-receptor complexes.

Authors:  D J Diestler; E W Knapp
Journal:  Phys Rev Lett       Date:  2008-04-28       Impact factor: 9.161

5.  The influence of rigid or flexible linkage between two ligands on the effective affinity and avidity for reversible interactions with bivalent receptors.

Authors:  S A Bobrovnik
Journal:  J Mol Recognit       Date:  2007 Jul-Aug       Impact factor: 2.137

6.  Using covalent dimers of human carbonic anhydrase II to model bivalency in immunoglobulins.

Authors:  Eric T Mack; Phillip W Snyder; Raquel Perez-Castillejos; George M Whitesides
Journal:  J Am Chem Soc       Date:  2011-07-07       Impact factor: 15.419

Review 7.  The therapeutic monoclonal antibody market.

Authors:  Dawn M Ecker; Susan Dana Jones; Howard L Levine
Journal:  MAbs       Date:  2015       Impact factor: 5.857

8.  Spatial control of membrane receptor function using ligand nanocalipers.

Authors:  Alan Shaw; Vanessa Lundin; Ekaterina Petrova; Ferenc Fördős; Erik Benson; Abdullah Al-Amin; Anna Herland; Andries Blokzijl; Björn Högberg; Ana I Teixeira
Journal:  Nat Methods       Date:  2014-07-06       Impact factor: 28.547

9.  Dependence of avidity on linker length for a bivalent ligand-bivalent receptor model system.

Authors:  Eric T Mack; Phillip W Snyder; Raquel Perez-Castillejos; Başar Bilgiçer; Demetri T Moustakas; Manish J Butte; George M Whitesides
Journal:  J Am Chem Soc       Date:  2011-12-21       Impact factor: 15.419

10.  In-depth analysis of subclass-specific conformational preferences of IgG antibodies.

Authors:  Xinsheng Tian; Bente Vestergaard; Matthias Thorolfsson; Zhiru Yang; Hanne B Rasmussen; Annette E Langkilde
Journal:  IUCrJ       Date:  2015-01-01       Impact factor: 4.769

View more
  1 in total

Review 1.  Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.

Authors:  William R Strohl; Zhiqiang Ku; Zhiqiang An; Stephen F Carroll; Bruce A Keyt; Lila M Strohl
Journal:  BioDrugs       Date:  2022-04-27       Impact factor: 7.744

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.